<DOC>
	<DOCNO>NCT02016664</DOCNO>
	<brief_summary>Oral ketamine increasingly use doctor reduce amount narcotic pain medication consume improve chronic pain management difficult case . How much absorb take orally , oppose intravenously , unknown . Ketamine may cause sedation , occasionally cognitive impairment . Therefore , safety concern associate usage out-patient may engage activity cognitive impairment dangerous , drive . This study design measure plasma concentration ketamine active metabolite , norketamine , people take low dose oral ketamine chronic pain . The goal study verify low dose oral ketamine produce plasma concentration level associate toxic symptom , thus safely used long-term treatment chronic pain .</brief_summary>
	<brief_title>Plasma Concentration Ketamine Norketamine .</brief_title>
	<detailed_description>This non-randomized , cohort study measure serum uptake low dose oral ketamine chronic pain patient . The SJHC pharmacy list patient dispense oral ketamine . We plan recruit fifteen patient patient group . This pilot study little information available help sample size calculation . We also plan measure change mean pain score Day Day 14 use Brief Pain Inventory ( BPI ) This data aid design calculation sample size future study . Study Design : Days 1-7 : Following informed consent , patient 's demographic information initial assessment complete Day 1 first visit . They allow continue usual systemic analgesic medication . They give instruction take study medication give list food could possibly induce inhibit enzyme , Cyp3A4 Cyp2B6 ( i.e . grapefruit grapefruit juice ) . Subjects give 7 day supply 10 mg ketamine tablet . The patient instruct take one ketamine tablet three time per day specify time seven day return clinic Day 7 . They instruct take morning dose ketamine eat light breakfast Day 7 . Upon arrival , patient complete Brief Pain Inventory side effect questionnaire . The patient 20 gauge ( saline lock ) IV start antecubital fossa allow five blood sample : Time Zero , 30 , 60 , 90 120 minute . The first blood sample Time 0 obtain patient take his/her oral dose ketamine ( trough concentration ) . The four remain sample take patient ingests his/her 10 mg ketamine dose . Time Activity Arrival Complete BPI , side effect questionnaire Time Zero Blood draw , take 10mg oral ketamine dose 30 minute post ingestion Blood draw 60 minute post ingestion Blood draw 90 minute post ingestion Blood draw 120 minute post-ingestion Blood Draw Days 8-14 : The subject give supply 20 mg ketamine capsule instruct take three time per day , specify time , return clinic Day 14 . The instruction procedure second clinic visit Day 7 .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Patient currently take oral ketamine treatment chronic neuropathic pain . Age &gt; 18 &lt; 75 year Both male females 4.Ability speak English adequately understand consent participate study No route ketamine within past 7 day ( Topical/IV ) Patient receive liver enzyme inducer inhibitor Cytochrome CYP3A4 , CYP2B6 like clarithromycin , rifampin , recent ingestion grapefruit juice . Patients gastric bypass surgery Patients follow prescribe protocol Renal Failure define Creatinine Clearance &lt; 50 mL/min Hepatic insufficiency history</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Chronic Pain , Ketamine , Safety</keyword>
</DOC>